Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...

Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

In a report released today, Jayson Bedford from Raymond James maintained a Buy rating on Boston Scientific (BSX – Research Report), with a ...

We recently compiled a list of the 12 Best Fundamental Stocks to Buy Now. In this article, we are going to take a look at ...

Boston Scientific initially developed the concept ... geopolitical events; manufacturing, distribution and supply chain disruptions and cost increases; disruptions caused by cybersecurity events ...

Boston Scientific BSX is slated to report fourth-quarter fiscal 2024 results on Feb. 5 before market open. See the Zacks Earnings Calendar to stay ahead of market-making news. For fourth-quarter ...

BOSTON--(BUSINESS ... the adoption of scientific AI to radically improve workflows across the entire biopharmaceutical value chain: drug discovery, development, manufacturing, and quality control.

At JP Morgan, he highlighted those two products as growth drivers ... The much-anticipated Farapulse approval last year made Boston Scientific the second company to earn an FDA nod for ...

Food manufacturers will have until January 2027 to remove the dye from their products, while makers ... “And if we don’t have the scientific evidence, we will lose in court.” ...

Agency officials also said they believe there’s another potential upshot to the rule: Manufacturers may reformulate their products to ... review of the scientific literature, review of schemes ...

“Claims that the use of FD&C Red No. 3 in food and in ingested drugs puts people at risk are not supported by the available scientific ... dye No. 3 from products, and drug manufacturers have ...